USP8 and hepatocellular carcinoma: USP8 knockdown also effectively inhibited proliferation (~50% to ~70%) and induced apoptosis (~20% to ~40%) in doxorubicin-resistant HCC cell lines (Figure 2E, 2F and Supplementary Figures 4, 5).